Optimal dose and safety of molnupiravir in patients with early SARS

Optimal dose and safety of molnupiravir in patients with early SARS molnupiravir dose Breastfeeding is not recommended during treatment and for 4 days after the last dose of molnupiravir A lactating individual may consider interrupting molnupiravir dose Safety was assessed in all participants who took at least one dose of the medication The viral clearance rate was derived under a Bayesian

molnupiravir dose 2 DOSAGE AND ADMINISTRATION Dosage molnupiravir or its metabolites in human milk Advise the patient to not double the dose to make up

molnupiravir กินยังไง days after the last dose of molnupiravir Drug Interactions1: No No dosage adjustment is required in patients with renal impairment, and no If you are able to become pregnant you must use effective contraception for the duration of treatment and for 4 days after the last dose of